Mucocutaneous symptoms at hospital admission may not predict severe MIS-C

Mucocutaneous symptoms among children hospitalized for suspected multisystem inflammatory syndrome in children may not predict a severe course of that syndrome, according to recent findings.
“There are few studies comparing severity of [multisystem inflammatory syndrome in children (MIS-C)] disease with mucocutaneous symptoms, age, race and ethnicity,” Megana Rao, BS, of Indiana University School of Medicine, Indianapolis, and colleagues wrote.
The retrospective cohort study included 66 patients hospitalized for suspected MIS-C between May 13, 2020, and April 21, 2021. Rao and

Mucocutaneous symptoms among children hospitalized for suspected multisystem inflammatory syndrome in children may not predict a severe course of that syndrome, according to recent findings.
“There are few studies comparing severity of [multisystem inflammatory syndrome in children (MIS-C)] disease with mucocutaneous symptoms, age, race and ethnicity,” Megana Rao, BS, of Indiana University School of Medicine, Indianapolis, and colleagues wrote.
The retrospective cohort study included 66 patients hospitalized for suspected MIS-C between May 13, 2020, and April 21, 2021. Rao and